Transformative Biotech LLC, a Boulder-based company working to develop faster molecular tests for diseases such as COVID-19 and cancer, has appointed Mark Kelleher as executive vice president of ...
Panels for use on the fully automated QIAstat-Dx Rise platform, marking the ninth U.S. QIAstat-Dx panel clearance in last 24 monthsLaboratories can now run respiratory and gastrointestinal panels, ...
Explore how proteomics enables personalized medicine by improving patient stratification, treatment response, and diagnostics ...
Explore how proteomics enhances infectious disease detection, pathogen identification, and host response profiling in ...
When an unidentified respiratory disease began circulating the world in early 2020, molecular biology researchers suddenly found that their work was the world’s top story. Efforts to identify the ...
Levels of six RNA molecules in the blood ID’d older adults likely to survive two more years. Whether it will work for other ...
What if doctors could tell you a disease was coming years before you felt a single symptom—and stop it in its tracks? That is ...
The COVID-19 pandemic brought the term "Polymerase Chain Reaction testing" into the mainstream. The PCR method is a type of ...
A rare clotting disorder puzzled doctors during the COVID vaccine rollout. New research reveals the unlikely chain of events ...
Spokane Delegation voting yes: Sen. Marcus Riccelli, D-Spokane; Sen. Jeff Holy, R-Cheney; Sen. Shelly Short, R-Addy; Sen. Mark Schoesler, R-Ritzville; Sen. Leonard ...
Multicancer assays leverage cfDNA methylation patterns to detect malignancy and infer tumor origin, with reported tissue-of-origin prediction approaching 87% accuracy in real-world experience. The 142 ...
Fluid Metering pumps offer a cost-efficient and dependable solution here, utilizing a protective barrier media known as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results